Top View
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Drug-Drug Interaction Data
- Cho-Ming Loi, Dennis A. Smith and Deepak Dalvie Pharmacokinetics
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- A Diversity Outbred ES Cell Platform for in Vitro Genetics
- (12) United States Patent (10) Patent No.: US 9.248,185 B2 Rubin Et Al
- Ranolazine in High Risk ICD Patients
- Drug-Induced QT-Interval Prolongation and Proarrhythmic Risk
- Ciprofloxacin; Cardiotoxicity; Hepatotoxicity; Humans; Animals
- Download PDF File
- Bioactive Compound Library Plus (96-Well)
- 210311 Wild Guided Report.Indd
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Life with Inherited Abnormal Heart Rhythms
- Research in Your Backyard Developing Cures, Creating Jobs
- Drug Repurposing Compound Library Plus (96-Well)
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- (12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
- WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
- Publications 1999.Pdf
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Drug Repurposing Compound Library (96-Well)
- 1111111111111111111Imnumu
- Relationship Among Amiodarone, New Class III Antiarrhytmics, Miscellaneous Agents and Acquired Long QT Syndrome
- Postgradmedj-2020-138661 1..7
- The American Journal of Cardiology
- UC San Francisco Electronic Theses and Dissertations
- BRE 186 Phase II Trial of Eribulin in Patients Who
- Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People
- WO 2007/016766 Al